19:52 , Feb 23, 2018 |  BioCentury  |  Emerging Company Profile

Cutting viruses

Armed with a suite of CRISPR nucleases and multiple guide RNAs, Excision BioTherapeutics Inc. is using gene editing to cut out integrated latent viruses from host genomes. The newco is starting with HIV, but has...
18:03 , Sep 1, 2017 |  BC Week In Review  |  Company News

CSL Behring acquires Calimmune

The CSL Behring subsidiary of CSL Ltd. (ASX:CSL) said it will acquire gene therapy company Calimmune Inc. (Tucson, Ariz.), gaining two...
20:33 , Aug 28, 2017 |  BC Extra  |  Company News

CSL Behring acquires Calimmune

The CSL Behring subsidiary of CSL Ltd. (ASX:CSL) said it will acquire gene therapy company Calimmune Inc. (Tucson, Ariz.), gaining two...
07:00 , Mar 31, 2016 |  BC Innovations  |  Tools & Techniques

Postmodern ART

The next frontier in HIV therapy is moving patients beyond antiretroviral therapy (ART), which involves daily cocktails of compounds that block replication and spread of the virus, taken either as separate or combined formulations. Because...
01:47 , May 28, 2015 |  BC Extra  |  Financial News

Calimmune raises $15M in series B

Gene therapy company Calimmune Inc. (Tucson, Ariz.) raised $15 million in a series B round led by AbbVie Biotech Ventures Inc., the venture arm of AbbVie Inc. (NYSE:ABBV). New investor Alexandria Venture Investments and existing...
07:00 , Jul 24, 2014 |  BC Innovations  |  Cover Story

It is an RNA world

RNA-based molecules have redefined the universe of tractable targets by putting virtually anything that is gene encoded within reach of a disease-modifying agent. This redefinition has launched RNA as the biotech industry's third drug modality....
07:00 , Jul 22, 2013 |  BC Week In Review  |  Clinical News

Cal-1: Phase I/II started

Calimmune began an open-label, U.S. Phase I/II to evaluate Cal-1 with and without conditioning agent Busulfex busulfan in 12 HIV-positive patients previously on highly active antiretroviral therapy (HAART). California Institute for Regenerative Medicine (San Francisco,...